Drug addiction: from bench to bedside

• Published in: Translational psychiatry 2021-08, Vol.11 (1), p.424-14, Article 424
• Main Authors: Cheron, Julian, Kerchove d’Exaerde, Alban de
• Format: Article
• Language: English
• Subjects: 631/378/340; 64/60; 692/699/476/5; Addictions; Behavior, Addictive; Behavioral Sciences; Biological Psychology; Brain; Humans; Medicine; Medicine & Public Health; Neuronal Plasticity; Neurosciences; Pharmacotherapy; Psychiatry; Review; Review Article; Substance-Related Disorders
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-021-01542-0

Drug addiction is responsible for millions of deaths per year around the world. Still, its management as a chronic disease is shadowed by misconceptions from the general public. Indeed, drug consumers are often labelled as “weak”, “immoral” or “depraved”. Consequently, drug addiction is often perceived as an individual problem and not societal. In technical terms, drug addiction is defined as a chronic, relapsing disease resulting from sustained effects of drugs on the brain. Through a better characterisation of the cerebral circuits involved, and the long-term modifications of the brain induced by addictive drugs administrations, first, we might be able to change the way the general public see the patient who is suffering from drug addiction, and second, we might be able to find new treatments to normalise the altered brain homeostasis. In this review, we synthetise the contribution of fundamental research to the understanding drug addiction and its contribution to potential novel therapeutics. Mostly based on drug-induced modifications of synaptic plasticity and epigenetic mechanisms (and their behavioural correlates) and after demonstration of their reversibility, we tried to highlight promising therapeutics. We also underline the specific temporal dynamics and psychosocial aspects of this complex psychiatric disease adding parameters to be considered in clinical trials and paving the way to test new therapeutic venues.